Literature DB >> 32369628

Convalescent donor SARS-COV-2-specific cytotoxic T lymphocyte infusion as a possible treatment option for COVID-19 patients with severe disease has not received enough attention till date.

Brian Hanley1, Candice A Roufosse1, Michael Osborn1, Kikkeri N Naresh1.   

Abstract

Entities:  

Keywords:  CD8+ T cells; COVID-19; NK cells; SARS-COV-2; cytotoxic cells

Mesh：

Year:  2020        PMID： 32369628     DOI： 10.1111/bjh.16780

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  7 in total

1.  COVID-19: more than a cytokine storm.

Authors:  Giovanni Riva; Vincenzo Nasillo; Enrico Tagliafico; Tommaso Trenti; Patrizia Comoli; Mario Luppi
Journal:  Crit Care       Date:  2020-09-04       Impact factor: 9.097

Review 2.  Cellular and Humoral Immune Responses in Covid-19 and Immunotherapeutic Approaches.

Authors:  Amal Hasan; Ebaa Al-Ozairi; Zahraa Al-Baqsumi; Rasheed Ahmad; Fahd Al-Mulla
Journal:  Immunotargets Ther       Date:  2021-03-09

3.  Reduced inflammatory responses to SARS-CoV-2 infection in children presenting to hospital with COVID-19 in China.

Authors:  Guoqing Qian; Yong Zhang; Yang Xu; Weihua Hu; Ian P Hall; Jiang Yue; Hongyun Lu; Liemin Ruan; Maoqing Ye; Jin Mei
Journal:  EClinicalMedicine       Date:  2021-04-15

4.  Rapid Manufacturing of Highly Cytotoxic Clinical-Grade SARS-CoV-2-specific T Cell Products Covering SARS-CoV-2 and Its Variants for Adoptive T Cell Therapy.

Authors:  Agnes Bonifacius; Sabine Tischer-Zimmermann; Maria Michela Santamorena; Philip Mausberg; Josephine Schenk; Stephanie Koch; Johanna Barnstorf-Brandes; Nina Gödecke; Jörg Martens; Lilia Goudeva; Murielle Verboom; Jana Wittig; Britta Maecker-Kolhoff; Herrad Baurmann; Caren Clark; Olaf Brauns; Martina Simon; Peter Lang; Oliver A Cornely; Michael Hallek; Rainer Blasczyk; Dominic Seiferling; Philipp Köhler; Britta Eiz-Vesper
Journal:  Front Bioeng Biotechnol       Date:  2022-04-04

Review 5.  A 21st Century Evil: Immunopathology and New Therapies of COVID-19.

Authors:  Taylon Felipe Silva; Fernanda Tomiotto-Pellissier; Raquel Arruda Sanfelice; Manoela Daiele Gonçalves; Bruna Taciane da Silva Bortoleti; Mariana Barbosa Detoni; Ana Carolina Jacob Rodrigues; Amanda Cristina Machado Carloto; Virgínia Márcia Concato; Elaine da Silva Siqueira; Idessania Nazareth Costa; Wander Rogério Pavanelli; Ivete Conchon-Costa; Milena Menegazzo Miranda-Sapla
Journal:  Front Immunol       Date:  2020-10-27       Impact factor: 7.561

6.  Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study.

Authors:  Brian Hanley; Kikkeri N Naresh; Candice Roufosse; Andrew G Nicholson; Justin Weir; Graham S Cooke; Mark Thursz; Pinelopi Manousou; Richard Corbett; Robert Goldin; Safa Al-Sarraj; Alireza Abdolrasouli; Olivia C Swann; Laury Baillon; Rebecca Penn; Wendy S Barclay; Patrizia Viola; Michael Osborn
Journal:  Lancet Microbe       Date:  2020-08-20

7.  Harnessing HLA-E-restricted CD8 T lymphocytes for adoptive cell therapy of patients with severe COVID-19.

Authors:  Nadia Caccamo; Lucy C Sullivan; Andrew G Brooks; Francesco Dieli
Journal:  Br J Haematol       Date:  2020-06-19       Impact factor: 8.615
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.